<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To determine the prevalence and clinical characteristics of <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e> occurring in a large series of patients diagnosed with <z:hpo ids='HP_0100778'>cryoglobulinemia</z:hpo>, and to study their association and overlap with autoimmune and/or <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0001799'>viral</z:mp> diseases </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: We retrospectively analyzed the occurrence of <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e> in 607 patients diagnosed with <z:hpo ids='HP_0100778'>cryoglobulinemia</z:hpo> in a single institution </plain></SENT>
<SENT sid="2" pm="."><plain>Clinical, histologic, and serologic characteristics of patients were recorded on a protocol form </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">Hematologic malignancies</z:e> were diagnosed according to the Revised European-American <z:hpo ids='HP_0002665'>Lymphoma</z:hpo>/World Health Organization classification criteria </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Of the total cohort of 607 patients with <z:hpo ids='HP_0100778'>cryoglobulinemia</z:hpo>, we retrospectively identified 27 patients (5%) in whom a <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancy</z:e> was diagnosed, including 24 (89%) lymphoproliferative and 3 (11%) <z:e sem="disease" ids="C0027022" disease_type="Neoplastic Process" abbrv="MPD">myeloid malignancies</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Fifteen (56%) were men and 12 (44%) women, with a median age at diagnosis of <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancy</z:e> of 67 years (range, 44 to 88 years) </plain></SENT>
<SENT sid="6" pm="."><plain>The identified <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e> were non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (n = 18), Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (n = 2), <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo> (n = 2), and 1 case each of <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo>, <z:e sem="disease" ids="C0024419" disease_type="Neoplastic Process" abbrv="">Waldenström macroglobulinemia</z:e>, <z:e sem="disease" ids="C0017531" disease_type="Disease or Syndrome" abbrv="GLNH|AFLH">Castleman disease</z:e>, <z:hpo ids='HP_0011010'>chronic</z:hpo> myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> and <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Of the 18 patients with non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, there was a predilection for specific histologic types (diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> in 8 cases and small lymphocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> in 4) and a higher frequency of a primary extranodal origin in 6 (33%) cases </plain></SENT>
<SENT sid="8" pm="."><plain>Conditions associated with <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e> were <z:hpo ids='HP_0012115'>hepatitis</z:hpo> C virus (HCV) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> in 14 patients (52%) and systemic <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo> in 13 (48%), with both HCV and systemic <z:hpo ids='HP_0002960'>autoimmune disease</z:hpo> in 6 cases (22%) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Hematologic <z:hpo ids='HP_0002664'>neoplasia</z:hpo> associated with <z:hpo ids='HP_0100778'>cryoglobulinemia</z:hpo> is defined by a clear predominance of <z:hpo ids='HP_0005523'>lymphoproliferative disorders</z:hpo> (mainly non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo>), with substantial extranodal involvement and an elevated presence of immunologic markers </plain></SENT>
<SENT sid="10" pm="."><plain>HCV <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> is the main etiologic factor associated with <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e> in patients with <z:hpo ids='HP_0100778'>cryoglobulinemia</z:hpo>, followed by specific systemic <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo> such as <z:e sem="disease" ids="C1527336" disease_type="Disease or Syndrome" abbrv="">Sjögren</z:e> syndrome and <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo>, highlighting the close relationship between lymphoproliferation, <z:hpo ids='HP_0002960'>autoimmunity</z:hpo>, and viruses </plain></SENT>
</text></document>